GEMAMEDIC

GEMAMEDIC has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €129,889 and a net result of €50,669. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 19% of 2,941 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).